Juna M. De Vries

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Neuronal Antibodies in Patients With Atypical Parkinsonism.

Neuronal Antibodies in Patients With Atypical Parkinsonism.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 24, 2026

Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 Disease.

Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 13, 2026

Stiff-person syndrome; the diagnostic challenges of a treatable condition

Stiff-person syndrome; the diagnostic challenges of a treatable condition

Journal: Nederlands tijdschrift voor geneeskunde

Published: June 02, 2026

Clinical Manifestations, Tumor Associations, and Long-Term Outcomes of Anti-KLHL11 Encephalitis.

Clinical Manifestations, Tumor Associations, and Long-Term Outcomes of Anti-KLHL11 Encephalitis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: May 29, 2026

Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia: A Multicenter Prospective Cohort Study.

Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia: A Multicenter Prospective Cohort Study.

Journal: Neurology

Published: May 15, 2026

Relapses, Comorbidities, and Predictors of Outcome in Anti-GABAA Receptor Encephalitis.

Relapses, Comorbidities, and Predictors of Outcome in Anti-GABAA Receptor Encephalitis.

Journal: Annals of neurology

Published: December 18, 2025

High Relapse Rate in Anti-CASPR2 Disease: Implications for Prolonged Immunotherapy.

High Relapse Rate in Anti-CASPR2 Disease: Implications for Prolonged Immunotherapy.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: December 16, 2025

A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.

A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.

Journal: Annals of neurology

Published: December 05, 2025

A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.

A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.

Journal: Annals of neurology

Published: December 05, 2025

Movement Disorders in Antibody-Associated Neurologic Diseases: A Nationwide Study.

Movement Disorders in Antibody-Associated Neurologic Diseases: A Nationwide Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: November 21, 2025

Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease.

Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease.

Journal: JAMA neurology

Published: August 04, 2025

Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort study.

Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort study.

Journal: The Lancet regional health. Europe

Published: July 24, 2025

Showing 1-12 of 46

Last Updated: 09/26/2026